Suppr超能文献

炎症性肠病的临床特征与治疗:东西方观点比较

Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives.

作者信息

Park Soo Jung, Kim Won Ho, Cheon Jae Hee

机构信息

Soo Jung Park, Won Ho Kim, Jae Hee Cheon, Department of Internal Medicine and Institute of Gastroenerology, Yonsei University College of Medicine, Seoul 120-752, South Korea.

出版信息

World J Gastroenterol. 2014 Sep 7;20(33):11525-37. doi: 10.3748/wjg.v20.i33.11525.

Abstract

Inflammatory bowel disease (IBD) is a chronic, relapsing intestinal inflammatory disorder with unidentified causes. Both environmental factors and genetic aspects are believed to be crucial to the pathogenesis of IBD. The incidence and prevalence of IBD have recently been increasing throughout Asia, presumably secondary to environmental changes. This increasing trend in IBD epidemiology necessitates specific health care planning and education in Asia. To this end, we must gain a precise understanding of the distinctive clinical and therapeutic characteristics of Asian patients with IBD. The phenotypes of IBD reportedly differ considerably between Asians and Caucasians. Thus, use of the same management strategies for these different populations may not be appropriate. Moreover, investigation of the Asian-specific clinical aspects of IBD offers the possibility of identifying causative factors in the pathogenesis of IBD in this geographical area. Accordingly, this review summarizes current knowledge of the phenotypic manifestations and management practices of patients with IBD, with a special focus on a comparison of Eastern and Western perspectives.

摘要

炎症性肠病(IBD)是一种病因不明的慢性复发性肠道炎症性疾病。环境因素和遗传因素都被认为对IBD的发病机制至关重要。近年来,IBD在亚洲的发病率和患病率不断上升,这可能是环境变化所致。IBD流行病学的这种上升趋势使得在亚洲有必要进行特定的医疗保健规划和教育。为此,我们必须准确了解亚洲IBD患者独特的临床和治疗特征。据报道,IBD的表型在亚洲人和白种人之间有很大差异。因此,对这些不同人群采用相同的管理策略可能并不合适。此外,对IBD亚洲特异性临床方面的研究为确定该地理区域IBD发病机制中的致病因素提供了可能性。因此,本综述总结了IBD患者表型表现和管理实践的当前知识,特别侧重于东西方观点的比较。

相似文献

1
Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives.
World J Gastroenterol. 2014 Sep 7;20(33):11525-37. doi: 10.3748/wjg.v20.i33.11525.
2
Inflammatory bowel disease in Asia: a systematic review.
J Gastroenterol Hepatol. 2012 Aug;27(8):1266-80. doi: 10.1111/j.1440-1746.2012.07150.x.
3
Genetics of inflammatory bowel diseases: a comparison between Western and Eastern perspectives.
J Gastroenterol Hepatol. 2013 Feb;28(2):220-6. doi: 10.1111/jgh.12053.
4
Differences in inflammatory bowel disease phenotype between South Asians and Northern Europeans living in North West London, UK.
Am J Gastroenterol. 2011 Jul;106(7):1281-9. doi: 10.1038/ajg.2011.85. Epub 2011 May 17.
8
Approach to a Child with Colitis.
Indian J Pediatr. 2016 Nov;83(12-13):1444-1451. doi: 10.1007/s12098-016-2091-5. Epub 2016 Apr 15.
10
Inflammatory bowel disease. Part II: Clinical and therapeutic aspects.
Dis Mon. 1991 Nov;37(11):669-746. doi: 10.1016/s0011-5029(05)80013-6.

引用本文的文献

3
Global geoepidemiology of gastrointestinal surgery rates in Crohn's disease.
World J Gastrointest Surg. 2024 Jun 27;16(6):1835-1844. doi: 10.4240/wjgs.v16.i6.1835.
4
Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus.
Nat Rev Gastroenterol Hepatol. 2024 Jun;21(6):377-405. doi: 10.1038/s41575-024-00932-1. Epub 2024 May 19.
5
Real-world efficacy and safety of tofacitinib treatment in Asian patients with ulcerative colitis.
World J Gastroenterol. 2024 Apr 7;30(13):1871-1886. doi: 10.3748/wjg.v30.i13.1871.
6
Duodenal Crohn's disease: Case report and systematic review.
World J Methodol. 2024 Mar 20;14(1):88619. doi: 10.5662/wjm.v14.i1.88619.
7
Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis.
Pharmaceuticals (Basel). 2024 Mar 7;17(3):347. doi: 10.3390/ph17030347.
10
IBD barriers across the continents - East Asia.
Therap Adv Gastroenterol. 2023 Nov 22;16:17562848231212089. doi: 10.1177/17562848231212089. eCollection 2023.

本文引用的文献

1
Similar clinical characteristics of familial and sporadic inflammatory bowel disease in South Korea.
World J Gastroenterol. 2014 Dec 7;20(45):17120-6. doi: 10.3748/wjg.v20.i45.17120.
5
Systematic review: the efficacy of herbal therapy in inflammatory bowel disease.
Aliment Pharmacol Ther. 2013 Oct;38(8):854-63. doi: 10.1111/apt.12464. Epub 2013 Aug 25.
6
Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic era.
Aliment Pharmacol Ther. 2013 Oct;38(7):752-60. doi: 10.1111/apt.12440. Epub 2013 Aug 26.
9
Crohn's disease and smoking: is it ever too late to quit?
J Crohns Colitis. 2013 Dec;7(12):e665-71. doi: 10.1016/j.crohns.2013.05.007. Epub 2013 Jun 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验